[In a patient undergoing mechanical ventilation for at least 3 days, does a 3-day course of inhaled amikacin reduce the incidence of ventilator-associated pneumonia compared to placebo, and is it safe?]

MeSH terms

• Amikacin* / therapeutic use
• Anti-Bacterial Agents / therapeutic use
• Humans
• Incidence
• Intensive Care Units
• Pneumonia, Ventilator-Associated* / drug therapy
• Pneumonia, Ventilator-Associated* / epidemiology
• Pneumonia, Ventilator-Associated* / prevention & control
• Respiration, Artificial / adverse effects